Related Experiment Videos
Health care cost of analgesic use in hypertensive patients
C Daniel Mullins1, Fadia T Shaya, Louis R Flowers
1Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, Maryland, USA. dmullins@rx.maryland.edu
Insights
Uncontrolled hypertension significantly increases healthcare costs for patients using analgesics. Managing blood pressure effectively can reduce expenses related to emergency visits and hospitalizations.
Area of Science:
- Medical Economics
- Cardiovascular Health
- Pharmacoeconomics
Background:
- Hypertension is a prevalent chronic condition in the US, posing significant financial and social burdens.
- Analgesic use is common among patients with hypertension.
- Effective hypertension management is crucial for reducing healthcare expenditure.
Purpose of the Study:
- To compare healthcare resource costs for hypertensive patients using analgesics.
- To stratify costs based on controlled versus uncontrolled hypertension status.
Main Methods:
- Retrospective analysis of managed-care patient data (February 1999 - July 2001).
- Stratification of hypertensive patients on analgesics by hypertension control using a claims-based algorithm.
- Comparison of annualized healthcare costs before and after analgesic initiation, stratified by hypertension control.
Main Results:
- Patients with uncontrolled hypertension incurred significantly higher total annualized costs ($2,568 more).
- Uncontrolled hypertension led to higher costs for emergency department visits (9.3%) and hospitalizations (28.0%).
- Post-index period costs were higher for uncontrolled hypertension ($2,961) compared to controlled ($1,972).
Conclusions:
- Healthcare resource costs are substantially higher for analgesic users with uncontrolled hypertension.
- A significant portion of the cost difference is linked to hypertension-specific treatment.
- Optimizing hypertension control in patients using analgesics may lead to considerable cost savings.
Background:
Hypertension is one of the most frequently diagnosed chronic medical conditions in the United States and imposes a substantial financial and social burden on Americans.
Objective:
The aim of this study was to compare the cost of health care resources for hypertensive patients taking analgesics stratified by having controlled versus uncontrolled hypertension.
Methods:
This was a retrospective, database analysis of data for managed-care patients in Maryland and Washington, DC, recorded from February 1, 1999, to July 31, 2001. Hypertensive patients who were taking analgesics were stratified by their hypertension control status using a claims-based algorithm. Annualized costs and differences in annualized costs calculated for the periods before and after the initiation of analgesics were compared by patient hypertension control status.
Results:
Of the 9805 patients in the study (mean [SD] age, 49.8 [12.04] years), 2523 (25.73%) were categorized as having uncontrolled hypertension. The mean total annualized costs differed significantly between the controlled and uncontrolled hypertension groups by 2568 dollars (P < 0.001). The annualized costs for emergency-department visits and hospitalizations for uncontrolled hypertensive patients exceeded those for controlled hypertensive patients by 9.3% and 28.0%, respectively. The differences between the postindex- and preindex-period costs for health care resources were 1972 dollars with controlled hypertension and 2961 dollars with uncontrolled hypertension (P < 0.001). The results of linear regression, after adjustments were made for preindex costs and other covariates, indicated that patients with uncontrolled hypertension had significantly increased billed annualized costs (P < 0.001).
Conclusions:
These data suggest that the costs of health care resources were significantly higher for analgesic users with uncontrolled hypertension than for analgesic users with controlled hypertension. A considerable proportion of the cost differential was directly attributable to hypertension-related treatment care.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management